Article | November 17, 2021

Mechanistic Modeling For Downstream Processing: Digital Twins Are Here To Stay

Source: Cytiva

By Tobias Hahn, Principal Scientist, Cytiva

iStock-1214111351-computer-lab

Across many industries, computer simulation has become an essential tool. Bioprocess development is only beginning to establish simulation-based workflows, despite the innovative nature of the biopharmaceutical industry.

Experts in the bioprocess industry agree that expensive and time-consuming laboratory experiments, iterative empirical optimization, and statistical methods alone cannot tackle future challenges. Therefore, many global biopharma companies are working on establishing digital twins of their upstream or downstream processes.

This article explores the types of digital twins as well as mechanistic modeling and chromatography models for the prediction and optimization of existing processes. Discover the important role that fully developed digital twins are likely to play.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: